Meeting
Abstract Number: 121
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: With standard diagnostic methods, the etiologic pathogen of community acquired pneumonia (CAP) is detected in ≤ 50% hospitalized CAP patients. In our previous studies using a diagnostic “bundle”, we were able to detect etiologic pathogens in ≥ 70 % of the patients. Our bundle consisted of a nasopharyngeal swab for Biofire film array, that […]
Abstract Number: 186
SHM Converge 2023
Background: For most infections, shorter antibiotic durations are similarly effective to longer durations but have lower risk for side effects and antibiotic resistance.1-9 Since 2019, community-acquired pneumonia (CAP) guidelines have recommended hospitalized patients with CAP be treated until clinical “stability and for no less than a total of 5 days.”10 However, randomized clinical trials have […]
Abstract Number: 229
Hospital Medicine 2020, Virtual Competition
Background: Identification of pathogens causing community-acquired pneumonia (CAP) in hospitalized patients has improved with the utilization of nasopharyngeal (NP) polymerase chain reaction (PCR). Literature shows that 20-25% of pathogens are identified when using urine antigens, sputum and blood cultures, and can improve up to 70% when adding NP PCR for viruses, Staphylococcus aureus and Streptococcus […]
Abstract Number: 275
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Approximately 1-2% of the U.S. population gets community-acquired pneumonia (CAP) annually in the U.S. and CAP is associated with substantial mortality, morbidity and costs. While the incidence of CAP is well-defined, the incidence of outpatients who fail antibiotics and eventually become hospitalized is less clear. The objective of this study was to provide real-world […]
Abstract Number: A11
SHM Converge 2022
Background: Community-acquired pneumonia (CAP) is the most common infectious diagnosis necessitating adult hospitalization in the United States (US). Timely diagnosis of CAP is important to improve patient outcomes. However, overdiagnosis of CAP, or treatment of CAP despite inadequate signs or symptoms of CAP, may also pose a significant threat to patient safety. Potential harm of […]